UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of ~~January~~May 2026

Commission File Number: 001-42835

HANG FENG TECHNOLOGY INNOVATION CO., LTD.

(Exact name of registrant as specified in its charter)

Unit 2806, 28/F, Tower One, Lippo Centre

No. 89 Queensway, Hong Kong

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒ Form 40-F ☐

~~Explanatory~~Other ~~Note~~Events

~~Hang~~Attached ~~Feng~~hereto ~~Technology~~as ~~Innovation Co~~Exhibit 99.,1 ~~Ltd.~~and ~~(the “Company”)~~Exhibit ~~is saddened to report that Mr~~99.2 ~~Wong~~is ~~Yiu Kit Ernest,~~ a ~~member~~notice of ~~the~~an ~~Company’s~~extraordinary ~~Board~~general ofmeeting ~~Directors~~ (the “~~Board~~Extraordinary General Meeting”), ~~the~~ ~~chair~~or “EGM”) of shareholders (the ~~Board’s~~“Notice”) ~~Audit Committee,~~ and a ~~member~~proxy ofcard (the ~~Compensation~~“Proxy ~~Committee~~Card”), ~~and~~respectively, ~~Nominating~~of ~~and~~Hang ~~Corporate~~Feng ~~Governance~~Technology ~~Committee,~~Innovation ~~passed away on January 24~~Co., ~~2026~~Ltd. ~~The~~(the “Company”) isrelating ~~grateful for Mr. Wong’s dedication and service~~ to the Company~~. The Company~~’s ~~management and~~Extraordinary ~~Board~~General ~~extends their sincere condolences to Mr~~Meeting. ~~Wong’s family.~~

~~Pursuant~~Where to ~~Nasdaq~~Find ~~Listing~~Additional Rule 5615(b), the Company is eligible for certain phase-in periods (the “Phase-in Period”) before it is required to fully comply with provisions of the majority independent board requirement of Nasdaq Listing Rule 5605(b), the audit committee requirements for Nasdaq Listing Rule 5605(c)(2), and the independent nominations and compensation committee requirements of Nasdaq Listing Rules 5605(d)(2) and 5605(e)(1)(B). The Company intends to appoint a new independent director prior to the end of the cure period to fill in the vacancy resulted from Mr. Wong’s passing.Information

The Company is a foreign private issuer. As such, the Notice is not subject to review and comment by the Securities and Exchange Commission (the “SEC”).

Shareholders are urged to carefully read the Notice, because it contains important information about the Company and the Extraordinary General Meeting of Shareholders. Copies of Notice and other documents filed or submitted by the Company will be available at the website maintained by the SEC at www.sec.gov. Shareholders may obtain a copy of such filings, free of charge, from the Company’s website at https://ir.hfintech.io/, or by writing to us at Unit 2806, 28/F, Tower One, Lippo Centre, No. 89 Queensway, Hong Kong.

Participants in the Solicitation

The Company and its directors and executive officers may be deemed to be participants in the solicitation of proxies from the shareholders of the Company in connection with the Extraordinary General Meeting of Shareholders. Information regarding certain directors and executive officers of the Company is available in the Company’s documents filed with or submitted to the SEC. Other information regarding the participants in the proxy solicitation and descriptions of their direct and indirect interests, by security holdings or otherwise, are set forth in the Notice filed herewith.

EXHIBIT INDEX

Exhibit No.		Description
99.1		Notice of Extraordinary General Meeting of Shareholders and Proxy Statement
99.2		Proxy Card

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Hang Feng Technology Innovation Co., Ltd.
Date: January 28, 2026	By:	/s/ XU Zhiheng
Date: May 1, 2026	By:	/s/ Zhiheng Xu
	Name:	XU Zhiheng Xu
	Title:	Chief Executive Officer

Filing Compare · Hang Feng Technology Innovation Co., Ltd.